Cancer-Causing Gut Bacteria

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A usually benign strain of the gut microbe E. coli produces toxins in mice with inflammatory bowel disease, which can lead to DNA-damage and cancer in the host tissue. The results were reported last week in Science (August 16).

“They're not exactly your flagship disease-causing bacteria,” lead researcher Christian Jobin, from the University of North Carolina at Chapel Hill, told Nature.

Individuals with inflammatory bowel disease are at higher risk of developing colorectal cancer than the general population. But researchers thought that the main culprit was the over-active immune cells, which released DNA-damaging molecules. The new work suggests that gut microbes may also contribute to the process, as inflammation appears to change the microbial composition of the gut to favor toxin-producing E. coli strains.

Experts think that the research could lead to methods of reducing the risk of cancer by altering the microbial community, though that strategy has to be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours